Clinical trials
Phase 1/2 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
448 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 8 |
| 2001 | 5 |
| 2002 | 7 |
| 2003 | 7 |
| 2004 | 11 |
| 2005 | 12 |
| 2006 | 16 |
| 2007 | 14 |
| 2008 | 13 |
| 2009 | 17 |
| 2010 | 24 |
| 2011 | 20 |
| 2012 | 19 |
| 2013 | 19 |
| 2014 | 17 |
| 2015 | 14 |
| 2016 | 16 |
| 2017 | 18 |
| 2018 | 16 |
| 2019 | 28 |
| 2020 | 9 |
| 2021 | 23 |
| 2022 | 21 |
| 2023 | 31 |
| 2024 | 17 |
| 2025 | 16 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 176 |
| Terminated | 83 |
| Recruiting | 67 |
| Unknown status | 56 |
| Active, not recruiting | 27 |
| Withdrawn | 18 |
| Not yet recruiting | 16 |
| Suspended | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 18 |
| M.D. Anderson Cancer Center | 12 |
| National Cancer Institute (NCI) | 12 |
| Fred Hutchinson Cancer Center | 11 |
| GlaxoSmithKline | 11 |
| Celgene | 8 |
| H. Lee Moffitt Cancer Center and Research Institute | 7 |
| Hackensack Meridian Health | 7 |
| Amgen | 6 |
| Incyte Corporation | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 448 |
| Neoplasms, Plasma Cell | 64 |
| Recurrence | 62 |
| Lymphoma | 45 |
| Lymphoma, Non-Hodgkin | 45 |
| Hodgkin Disease | 41 |
| Leukemia, Myeloid, Acute | 40 |
| Leukemia | 39 |
| Myelodysplastic Syndromes | 34 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 32 |
Trials
Showing 1 to 25 of 448. Each trial links to its page on Pharma Observatory.
348 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.